Ingevity CorpNGVT
Market cap
$1.8B
P/E ratio
| Dec 31, 2016 | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | |
| Net sales | - | - | 1,134 | 1,293 | 1,216 | 1,392 | 1,668 | 1,692 | 1,406 |
| Cost of sales | - | - | 717 | 811 | 751 | 879 | 1,098 | 1,220 | 952 |
| Gross profit | 274 | 329 | 417 | 482 | 466 | 513 | 570 | 472 | 455 |
| Selling, General and Administrative Expense | 114 | 106 | 132 | 163 | 149 | 179 | 199 | 184 | 167 |
| Research and technical expenses | - | 20 | 22 | 20 | 23 | 26 | 30 | 32 | 28 |
| Restructuring And Other Expense (Income) | - | - | - | - | - | - | - | - | 186 |
| Goodwill, Impairment Loss | - | - | - | - | - | - | - | - | 349 |
| Acquisition-related costs | - | 7 | 11 | 27 | 2 | 1 | 5 | 4 | 0 |
| Other (income) expense, net | - | - | - | - | - | - | - | - | -170 |
| Interest expense | - | - | - | - | - | - | - | - | 98 |
| Interest income | - | - | - | 8 | 5 | 4 | 8 | 6 | 8 |
| Income (loss) before income taxes | 87 | 175 | 222 | 228 | 235 | 163 | 270 | -10 | -536 |
| Income Tax Expense (Benefit) | 43 | 30 | 40 | 44 | 54 | 45 | 58 | -5 | -105 |
| Net income (loss) | 44 | 145 | 182 | 184 | 181 | 118 | 212 | -5 | -430 |
| Earnings Per Share, Basic | 0.83 | 3 | 4.02 | 4.39 | 4.39 | 2.97 | 5.54 | -0.15 | -11.85 |
| Earnings Per Share, Diluted | 0.83 | 2.97 | 3.97 | 4.35 | 4.37 | 2.95 | 5.5 | -0.15 | -11.85 |